Family C1 cysteine proteases: Biological diversity or redundancy?

Biological Chemistry

Volumn 384, Issue 6, 2003, Pages 837-843

  Nägler, Dorit K ^a   Ménard, Robert ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Cathepsin; Papain like; Peptidase; Specificity

Indexed keywords

CATHEPSIN; CYSTEINE PROTEINASE; PAPAIN;

AMINO ACID SUBSTITUTION; BIODIVERSITY; CELLULAR DISTRIBUTION; ENZYME SPECIFICITY; KNOCKOUT MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; STRUCTURE ANALYSIS;

ANIMALS; CYSTEINE ENDOPEPTIDASES; EVOLUTION, MOLECULAR; GENE DELETION; HUMANS; SEQUENCE HOMOLOGY, AMINO ACID; VARIATION (GENETICS);

EID: 0037810410     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2003.094     Document Type: Review

References (62)

1. Berardi, S., Lang, A., Kostoulas, G., Horler, D., Vilei, E.M., and Baici, A. (2001). Alternative messenger RNA splicing and enzyme forms of cathepsin B in human osteoarthritic cartilage and cultured chondrocytes. Arthritis Rheum. 44, 1819-1831.
2. Berquin, I.M., Cao, L., Fong, D., and Sloane, B.F. (1995). Identification of two new exons and multiple transcription start points in the 5′-untranslated region of the human cathepsin-B-encoding gene. Gene 159, 143-149.
3. Berti, P.J. and Storer, A.C. (1995). Alignment/phylogeny of the papain superfamily of cysteine proteases. J. Mol. Biol. 246, 273-283.
4. Bossard, M.J., Tomaszek, T.A., Thompson, S.K., Amegadzie, B.Y., Hanning, C.R., Jones, C., Kurdyla, J.T., McNulty, D.E., Drake, F.H., Gowen, M., and Levy, M.A. (1996). Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification. J. Biol. Chem. 271, 12517-12524.
5. Brömme, D. and Okamoto, K. (1995). Human cathepsin O2, a novel cysteine protease highly expressed in osteoclastomas and ovary molecular cloning, sequencing and tissue distribution. Biol. Chem. Hoppe-Seyler 376, 379-384.
6. Brömme, D. and Kaleta, J. (2002). Thiol-dependent cathepsins: pathophysiological implications and recent advances in inhibitor design. Curr. Pharm. Des. 8, 1639-1658.
7. Brömme, D., Li, Z., Barnes, M., and Mehler, E. (1999). Human cathepsin V functional expression, tissue distribution, electrostatic surface potential, enzymatic characterization, and chromosomal localization. Biochemistry 38, 2377-2385.
8. Bühling, F., Fengler, A., Brandt, W., Welte, T., Ansorge, S., and Nägler, D.K. (2000). Review: novel cysteine proteases of the papain family. Adv. Exp. Med. Biol. 477, 241-254.
9. Chapman, H.A., Riese, R.J., and Shi, G.P. (1997). Emerging roles for cysteine proteases in human biology. Annu. Rev. Physiol. 59, 63-88.
10. Coulombe, R., Grochulski, P., Sivaraman, J., Ménard, R., Mort, J.S., and Cygler, M. (1996). Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment. EMBO J. 15, 5492-5503.
11. Cygler, M. and Mort, J.S. (1997). Proregion structure of members of the papain superfamily. Mode of inhibition of enzymatic activity. Biochimie 79, 645-652.
12. Delaisse, J., Engsig, M.T., Everts, V., del Carmen, O.M., Ferreras, M., Lund, L., Vu, T.H., Werb, Z., Winding, B., Lochter, A. et al. (2000). Proteinases in bone resorption: obvious and less obvious roles. Clin. Chim. Acta 291, 223-234.
13. Denizot, F., Brunet, J.F., Roustan, P., Harper, K., Suzan, M., Luciani, M.F., Mattei, M.G., and Golstein, P. (1989). Novel structures CTLA-2 alpha and CTLA-2 beta expressed in mouse activated T cells and mast cells and homologous to cysteine proteinase proregions. Eur. J. Immunol. 19, 631-635.
14. Deussing, J., Roth, W., Saftig, P., Peters, C., Ploegh, H.L., and Villadangos, J.A. (1998). Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation. Proc. Natl. Acad. Sci. USA 95, 4516-4521.
15. Felbor, U., Kessler, B., Mothes, W., Goebel, H.H., Ploegh, H.L., Bronson, R.T., and Olsen, B.R. (2002). Neuronal loss and brain atrophy in mice lacking cathepsins B and L. Proc. Natl. Acad. Sci. USA 99, 7883-7888.
16. Gelb, B.D., Shi, G.P., Chapman, H.A., and Desnick, R.J. (1996). Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273, 1236-1238.
17. Gelb, B.D., Shi, G.P., Heller, M., Weremowicz, S., Morton, C., Desnick, R.J., and Chapman, H.A. (1997). Structure and chromosomal assignment of the human cathepsin K gene. Genomics 41, 258-262.
18. Groves, M.R., Coulombe, R., Jenkins, J., and Cygler, M. (1998). Structural basis for specificity of papain-like cysteine protease proregions toward their cognate enzymes. Proteins 32, 504-514.
19. Guncar, G., Podobnik, M., Pungercar, J., Strukelj, B., Turk, V., and Turk, D. (1998). Crystal structure of porcine cathepsin H determined at 2.1 Å resolution: location of the mini-chain C-terminal carboxyl group defines cathepsin H aminopeptidase function. Structure 6, 51-61.
20. Halangk, W., Lerch, M.M., Brandt-Nedelev, B., Roth, W., Ruthenbuerger, M., Reinheckel, T., Domschke, W., Lippert, H., Peters, C., and Deussing, J. (2000). Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J. Clin. Invest. 106, 773-781.
21. + T cell selection independently of its effect on invariant chain: a role in the generation of positively selecting peptide ligands. J. Exp. Med. 195, 1349-1358.
22. Jasmer, D.P., Roth, J., and Myler, P.J. (2001). Cathepsin B-like cysteine proteases and Caenorhabditis elegans homologues dominate gene products expressed in adult Haemonchus contortus intestine. Mol. Biochem. Parasitol. 116, 159-169.
23. Koblinski, J.E., Ahram, M., and Sloane, B.F. (2000). Unraveling the role of proteases in cancer. Clin. Chim. Acta 291, 113-135.
24. Lemaire, R., Flipo, R.M., Migaud, H., Fontaine, C., Huet, G., Dacquembronne, E., and Lafyatis, R. (1997). Alternative splicing of the 5′ region of cathepsin B pre-messenger RNA in rheumatoid synovial tissue. Arthritis Rheum. 40, 1540-1542.
25. Leung-Toung, R., Li, W., Tam, T.F., and Karimian, K. (2002). Thiol-dependent enzymes and their inhibitors: a review. Curr. Med. Chem. 9, 979-1002.
26. + T-lymphocytes. FEBS Lett. 405, 253-259.
27. Lustigman, S., McKerrow, J.H., Shah, K., Lui, J., Huima, T., Hough, M., and Brotman, B. (1996). Cloning of a cysteine protease required for the molting of Onchocerca volvulus third stage larvae. J. Biol. Chem. 271, 30181-30189.
28. Mason, R.W., Stabley, D.L., Picerno, G.N., Frenck, J., Xing, S., Bertenshaw, G.P., and Sol-Church, K. (2002). Evolution of placental proteases. Biol. Chem. 383, 1113-1118.
29. Matsui, K., Yuyama, N., Akaiwa, M., Yoshida, N.L., Maeda, M., Sugita, Y., and Izuhara, K. (2002). Identification of an alternative splicing variant of cathepsin C/dipeptidyl-peptidase I. Gene 293, 1-7.
30. Musil, D., Zucic, D., Turk, D., Engh, R.A., Mayr, I., Huber, R., Popovic, T., Turk, V., Towatari, T., and Katunuma, N. (1991). The refined 2.15 Å X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity. EMBO J. 10, 2321-2330.
31. Nakagawa, T.Y. and Rudensky, A.Y. (1999). The role of lysosomal proteinases in MHC class II-mediated antigen processing and presentation. Immunol. Rev. 172, 121-129.
32. Nakagawa, T., Roth, W., Wong, P., Nelson, A., Farr, A., Deussing, J., Villadangos, J.A., Ploegh, H., Peters, C., and Rudensky, A.Y. (1998). Cathepsin L: critical role in li degradation and CD4 T cell selection in the thymus. Science 280, 450-453.
33. Nakagawa, T.Y., Brissette, W.H., Lira, P.D., Griffiths, R.J., Petrushova, N., Stock, J., McNeish, J.D., Eastman, S.E., Howard, E.D., Clarke, S.R. et al. (1999). Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity 10, 207-217.
34. Navab, R., Chevet, E., Authier, F., Di Guglielmo, G.M., Bergeron, J.J., and Brodt, P. (2001). Inhibition of endosomal insulin-like growth factor-I processing by cysteine proteinase inhibitors blocks receptor-mediated functions. J. Biol. Chem. 276, 13644-13649.
35. Nägler, D.K., Sulea, T., and Ménard, R. (1999a). Full-length cDNA of human cathepsin F predicts the presence of a cystatin domain at the N-terminus of the cysteine protease zymogen. Biochem. Biophys. Res. Commun. 257, 313-318.
36. Nägler, D.K., Tam, W., Storer, A.C., Krupa, J.C., Mort, J.S., and Ménard, R. (1999b). Interdependency of sequence and positional specificities for cysteine proteases of the papain family. Biochemistry 38, 4868-4874.
37. Nägler, D.K., Zhang, R., Tam, W., Sulea, T., Purisima, E.O., and Ménard, R. (1999c). Human cathepsin X: a cysteine protease with unique carboxypeptidase activity. Biochemistry 38, 12648-12654.
38. Olsen, J.G., Kadziola, A., Lauritzen, C., Pedersen, J., Larsen, S., and Dahl, S.W. (2001). Tetrameric dipeptidyl peptidase I directs substrate specificity by use of the residual pro-part domain(1). FEBS Lett. 506, 201-206.
39. Pham, C.T. and Ley, T.J. (1999). Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo. Proc. Natl. Acad. Sci. USA 96, 8627-8632.
40. Rawlings, N.D., O'Brien, E., and Barrett, A.J. (2002). MEROPS: the protease database. Nucleic Acids Res. 30, 343-346.
41. Rehman, A. and Jasmer, D.P. (1999). Defined characteristics of cathepsin B-like proteins from nematodes: inferred functional diversity and phylogenetic relationships. Mol. Biochem. Parasitol. 102, 297-310.
42. Reinheckel, T., Deussing, J., Roth, W., and Peters, C. (2001). Towards specific functions of lysosomal cysteine peptidases: phenotypes of mice deficient for cathepsin B or cathepsin L. Biol. Chem. 382, 735-741.
43. Rescheleit, D.K., Rommerskirch, W.J., and Wiederanders, B. (1996). Sequence analysis and distribution of two new human cathepsin L splice variants. FEBS Lett. 394, 345-348.
44. Riese, R.J., Wolf, P.R., Bromme, D., Natkin, L.R., Villadangos, J.A., Ploegh, H.L., and Chapman, H.A. (1996). Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 4, 357-366.
45. Robinson, J.H. and Delvig, A.A. (2002). Diversity in MHC class II antigen presentation. Immunology 105, 252-262.
46. Roth, W., Deussing, J., Botchkarev, V.A., Pauly-Evers, M., Saftig, P., Hafner, A., Schmidt, P., Schmahl, W., Scherer, J., Anton-Lamprecht, I. et al. (2000). Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling. FASEB J. 14, 2075-2086.
47. Saftig, P., Hunziker, E., Wehmeyer, O., Jones, S., Boyde, A., Rommerskirch, W., Moritz, J.D., Schu, P., and von Figura, K. (1998). Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proc. Natl. Acad. Sci. USA 95, 13453-13458.
48. Sakai, K., Ren, S., and Schwartz, L.B. (1996). A novel heparin-dependent processing pathway for human tryptase. Autocatalysis followed by activation with dipeptidyl peptidase I. J. Clin. Invest. 97, 988-995.
49. Santamaria, I., Velasco, G., Pendas, A.M., Paz, A., and Lopez-Otin, C. (1999). Molecular cloning and structural and functional characterization of human cathepsin F, a new cysteine proteinase of the papain family with a long propeptide domain. J. Biol. Chem. 274, 13800-13809.
50. Shi, G.P., Bryant, R.A., Riese, R., Verhelst, S., Driessen, C., Li, Z., Brömme, D., Ploegh, H.L., and Chapman, H.A. (2000). Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages. J. Exp. Med. 191, 1177-1186.
51. Sivaraman, J., Nägler, D.K., Zhang, R., Ménard, R., and Cygler, M. (2000). Crystal structure of human procathepsin X: a cysteine protease with the proregion covalently linked to the active site cysteine. J. Mol. Biol. 295, 939-951.
52. Sol-Church, K., Picerno, G.N., Stabley, D.L., Frenck, J., Xing, S., Bertenshaw, G.P., and Mason, R.W. (2002). Evolution of placentally expressed cathepsins. Biochem. Biophys. Res. Commun. 293, 23-29.
53. Storer, A.C. and Ménard, R. (1996). Recent insights into cysteine protease specificity: lessons for drug design. Persp. Drug Discovery Des. 6, 33-46.
54. Stypmann, J., Glaser, K., Roth, W., Tobin, D.J., Petermann, I., Matthias, R., Monnig, G., Haverkamp, W., Breithardt, G., Schmahl, W. et al. (2002). Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L. Proc. Natl. Acad. Sci. USA 99, 6234-6239.
55. Tepel, C., Brömme, D., Herzog, V., and Brix, K. (2000). Cathepsin K in thyroid epithelial cells: sequence, localization and possible function in extracellular proteolysis of thyroglobulin. J. Cell Sci. 113, 4487-4498.
56. Toomes, C., James, J., Wood, A.J., Wu, C.L., McCormick, D., Lench, N., Hewitt, C., Moynihan, L., Roberts, E., Woods, C.G. et al. (1999). Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nature Genet. 23, 421-424.
57. Turk, V., Turk, B., and Turk, D. (2001a). Lysosomal cysteine proteases: facts and opportunities. EMBO J. 20, 4629-4633.
58. Turk, D., Janjic, V., Stern, I., Podobnik, M., Lamba, D., Dahl, S.W., Lauritzen, C., Pedersen, J., Turk, V., and Turk, B. (2001b). Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases. EMBO J. 20, 6570-6582.
59. Villadangos, J.A. and Ploegh, H.L. (2000). Proteolysis in MHC class II antigen presentation: who's in charge? Immunity 12, 233-239.
60. Waghray, A., Keppler, D., Sloane, B.F., Schuger, L., and Chen, Y.Q. (2002). Analysis of a truncated form of cathepsin H in human prostate tumor cells. J. Biol. Chem. 277, 11533-11538.
61. Ward, W., Alvarado, L., Rawlings, N.D., Engel, J.C., Franklin, C., and McKerrow, J.H. (1997). A primitive enzyme for a primitive cell: the protease required for excystation of Giardia. Cell 89, 437-444.
62. Wolters, P.J., Pham, C.T., Muilenburg, D.J., Ley, T.J., and Caughey, G.H. (2001). Dipeptidyl peptidase I is essential for activation of mast cell chymases, but not tryptases, in mice. J. Biol. Chem. 276, 18551-18556.